CompletedNot Applicable

Antimicrobial Stewardship Program for Clostridium Difficile Infection.

Spain403 participantsStarted 2017-02-15

Plain-language summary

The purpose of this study is to determine whether a bundle of measures specifically designed for patients with ICD and applied by and Infectious Diseases expert during a year period (2017) will improve the prognosis and reduce the rate of recurrence, compared with the baseline phase (2015) in which no intervention was made.

Who can participate

Age range18 Years – 110 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Patients diagnosed with CDI in the University Hospital "12 de Octubre", Madrid, Spain, requiring hospitalization or emergency room admission longer than 48 hours, from the beginning of the study on (estimated start date: January 2017). * Patient or his/her representative sign the inform consent Exclusion Criteria: * Patients younger than 18 years of age. * Patients with the diagnosis of inflammatory bowel disease.

What they're measuring

Number of Participants With Clostridium Difficile Infection Recurrence.

Timeframe: Within 8 weeks after the end of treatment.

Trial details

NCT IDNCT02951481

SponsorJosé María Aguado García, MD, PhD

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2017-12-15

Results submitted2020-07-28

View on ClinicalTrials.gov More Clostridium Difficile trials